Evidence map›Paper›PMID 38954224›Full record

ArticleAAPS PharmSciTech2024

Formulation and Characterization of Silibinin Entrapped Nano-Liquid Crystals for Activity against Aβ

Ajit Singh, Debarati Rakshit, Ankit Kumar, Awanish Mishra, Rahul Shukla

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ajit SinghDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, Uttar Pradesh, 226002, India.
Debarati RakshitDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Guwahati, Changsari, Kamrup, Assam-781101, India.
Ankit KumarDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Guwahati, Changsari, Kamrup, Assam-781101, India.
Awanish MishraDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Guwahati, Changsari, Kamrup, Assam-781101, India.
Rahul ShuklaDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, Uttar Pradesh, 226002, India. rahul.shukla@niperraebareli.edu.in.ORCID http://orcid.org/0000-0002-4864-0133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silibinin (SIL) Encapsulated Nanoliquid Crystalline (SIL-NLCs) particles were prepared to study neuroprotective effect against amyloid beta (Aβ

Indexed as

Amyloid beta-PeptidesMice, Inbred BALB CNeuroprotective AgentsPeptide FragmentsSilybinAcetylcholinesteraseAlzheimer DiseaseAnimalsBrainDisease Models, AnimalMaleMiceNanoparticlesParticle SizeReactive Oxygen SpeciesAcetylcholinesteraseAmyloid beta-Peptidesamyloid beta-protein (1-42)Neuroprotective AgentsPeptide FragmentsReactive Oxygen SpeciesSilybinalzheimer’s disease and in-vivo studiesamyloid betananoliquid crystalssilibinin

Identifiers

PMID38954224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.